Please see the below announcement from our friends in DLAM. Please contact Dr. Torres (CTorresUrbano@mednet.ucla.edu) or Ms. Schimmel (ASchimmel@mednet.ucla.edu) if you have any questions. MediGel Cups No Longer Available from Clear H2O – Carprofen Cups Are Available Ready-Made in the DLAM Pharmacy Until further notice, ClearH2O has made the decision, in consultation with the FDA, to stop the manufacturing, marketing … Read More
NEW & UPDATED ARC POLICIES
The ARC recently approved the following Policies: 1. Humane Treatment and Endpoints This new Policy establishes the ARC expectation for application of humane interventions to minimize pain and distress, and sets out criteria that warrant prompt premature euthanasia. Note that the standard premature euthanasia weight loss limit has been increased to 20% in the Policy; use of this endpoint, or … Read More
Waste Anesthetic Gas (WAG) Tutorial Series
The below announcement is shared on behalf of our colleagues in EH&S. Please contact Industrial Hygiene Manager Neil Mansky with any questions. The following Waste Anesthetic Gas awareness videos are now available for viewing on Worksafe. These videos are highly recommended for all users of table top lab animal anesthesia systems to better understand the proper setup and use of … Read More
Updated and New Biosafety SOPs
UCLA’s Institutional Biosafety Committee (IBC) works with Environment, Health & Safety to maintain a set of standardized Biosafety SOPs available to campus research labs. As a part of the 2018 annual review process the IBC approved the following changes to three of these SOPs. If you are currently using the standard Biosafety SOPs, no action by your laboratory is required. … Read More
IBC POLICY UPDATE
The Institutional Biosafety Committee (IBC) has updated the Policy, Registration of Transgenic Animals. Changes to the Policy are largely administrative, reflecting updates published in the 2016 NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. We encourage you to share and discuss the updated Policy with your research team. Please do not hesitate to contact us at 310-794-0262 … Read More
ARC Office Hours
The Animal Research Committee (ARC) administrative staff are now available for in-person assistance during a weekly office hour starting on Wednesday, February 20, 2019: Who? ARC Administrator Jacob J. Lopez or his designee When? Wednesdays, 11:00 am – 12:00 pm Where? CHS 17-132A We encourage you to stop by with your questions about the ARC review process, DLAM processes, and … Read More
ARC POLICY UPDATE
The ARC recently revised the Policy, Tracking and Reporting Animal Numbers, to clarify DLAM practices and conditions associated with submitting an annual report of in-house breeding activities to the ARC. The revised Policy is available at the Tracking and Reporting Animal Numbers web page. We encourage you to review the revised Policy with your research team. Please do not hesitate … Read More
3Rs Pilot Studies Call for Proposals – Deadline for Submission: March 1, 2019
The Research Safety & Animal Welfare Administration (RSAWA) is pleased to announce the Winter 2019 3Rs funding opportunity, provided by the Office of the Vice Chancellor for Research. Note that two awards, each up to $10,000, may be awarded this round. Aim of Award: The aim of the program is to promote and support pilot studies designed to replace the use … Read More
Comment on Draft Report: Reducing Administrative Burden for Animal Care and Use in Research
Please see the below announcement from our colleagues at the NIH requesting your feedback on the draft report and proposed recommendations from the 21st Century Cures Act, Section 2034(d) workgroup. The report includes recommendations aimed at alleviating administrative burden on investigators who use animal subjects in their research activities. As a member of the regulated community, we encourage you to … Read More
IMPORTANT ANNOUNCEMENT: MRSC/RDRC Continuing Review
The following announcement is shared with you on behalf of the Medical Radiation Safety Committee (MRSC) and Radioactive Drug Research Committee (RDRC): Continuing Review: As mentioned during the launch of the New SafetyNet system for the MRSC/RDRC, effective January 2, 2019, all approved MRSC/RDRC submissions, including those migrated into the new system, will be subject to continuing review (CR). CR … Read More